Evren Alici

Company: Karolinska Institutet

Job title: Group leader, Cell and Gene Therapy

Seminars:

Panel Discussion: Evading Identification by the Host Immune System to Prevent Immunological Rejection 3:30 pm

Exploring and comparing the different gene edits designed to overcome the major pathways of host versus graft rejection Discussing the regulatory issues and hurdles that appear when trying to make multiple modifications to overcome graft rejectionRead more

day: Day One Track B PM

Moving the Needle on Graft Rejection with Novel Strategies for T Cell Manipulation 2:30 pm

Exploring cell engineering to manipulate T-cells for elimination of the molecules responsible for rejection Discussing how to use gene editing to simultaneously prevent rejection and enhance the function of the allogeneic T cell. Incorporating new gene edits designed to avoid recognition by patient/host CD8+ T cells, CD4+ T cells and NK cells.Read more

day: Day One Track B PM